Chloe Orkin

30PUBLICATIONS
80CO-AUTHORS
Regenerative medicine (incl. stem cells)PharmacogenomicsHaematologyHealth informatics and information systemsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 29, 2026
Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.

|Jun 12, 2026
Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1.

|Mar 11, 2026
What Are the Causes and Consequences of Virological Failure on Long-acting Cabotegravir/Rilpivirine?

Andrew Hill, Chloe Orkin

|Feb 13, 2026
Risk of hypertension in people with HIV in the USA initiating modern antiretroviral regimens: pooled analysis of blood pressure data from five clinical trials.

Priscilla Y Hsue, Laura Waters, Chloe Orkin

|Dec 31, 2025
Supporting long-term engagement in HIV clinical care: Learning from the COVID-19 pandemic.

R Dhairyawan, Sara Paparini, M Smuk

|Nov 24, 2025
Factors Associated With Weight Change After Continuing or Switching to a Doravirine-based Regimen.

Chloe Orkin, John R Koethe, Princy N Kumar

Pageof 5

Frequent Collaborators

7 joint publications

Sara Paparini

4 joint publications

Kyle Ring

4 joint publications

Rosalie Hayes

3 joint publications

Rageshri Dhairyawan